10 Comments
Add this link to...
Tell a friend
Bury
11 Comments
Add this link to...
Tell a friend
Bury
14 Comments
Add this link to...
Tell a friend
Bury
11 Comments
Add this link to...
Tell a friend
Bury
11 Comments
Add this link to...
Tell a friend
Bury
11 Comments
Add this link to...
Tell a friend
Bury
A trial has begun on a vaccine treating pancreatic cancer, which has the lowest survival rate of all common cancers.
More than 1,000 patients with advanced pancreatic cancer have joined the TeloVac trial at 53 UK hospitals.
Vaccines are usually associated with preventing infections,
but this is part of a new approach to try to stimulate the immune system
to fight cancer.
19 Comments
Add this link to...
Tell a friend
Bury
|